JMP Securities upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Market Underperform to Market Outperform with a price target of $60.00 (from $10.00).

For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.

Shares of Sarepta Therapeutic closed at $28.15 yesterday.